No connection

Search Results

DRD

BULLISH
$29.13 Live
DRDGOLD Limited · NYSE
Target $46.5 (+59.6%)
$12.75 52W Range $39.37

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 26, 2026
Market cap
$2.53B
P/E
18.55
ROE
34.7%
Profit margin
35.1%
Debt/Equity
0.0
Dividend yield
2.03%

AI Analysis

AI-powered fundamental assessment

Confidence
85%
DRD exhibits exceptional fundamental health, highlighted by a strong Piotroski F-Score of 8/9 and a pristine balance sheet with zero debt. While the stock trades at a premium to its Graham Number ($16.31), it remains significantly undervalued relative to its intrinsic value ($46.32) and analyst target price ($46.50). High profitability margins and an impressive ROE of 34.71% suggest a highly efficient operation. Despite a bearish technical trend and weak insider sentiment, the underlying financial strength and growth trajectory provide a compelling bullish case.

Key Strengths

Exceptional financial health with 0.00 Debt/Equity ratio
Strong Piotroski F-Score (8/9) indicating high operational efficiency
High profitability with an Operating Margin of 46.29% and ROE of 34.71%
Significant growth momentum with 97.90% YoY earnings growth
Strong liquidity position with a Current Ratio of 3.01

Key Risks

Bearish technical trend (0/100) suggesting short-term price pressure
Forward P/E (42.84) is significantly higher than current P/E (18.55), suggesting a projected earnings decline
Low insider sentiment (40/100) may indicate internal caution
High Price/Book ratio (3.87) compared to traditional value benchmarks
Concentration risk inherent to the gold industry and commodity price volatility
AI Fair Value Estimate
Based on comprehensive analysis
$41.32
+41.8% above current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
78
Strong
Value
70
Future
75
Past
90
Health
98
Dividend
55
AI Verdict
Strong Fundamental Value
Key drivers: Zero debt, High ROE, Piotroski 8/9, Significant upside to intrinsic value
Confidence
90%
Value
70/100

Ref P/E, PEG, Graham Number

Positives
  • P/E (18.55) is well below sector average (37.28)
  • PEG ratio of 1.00 indicates fair valuation relative to growth
Watchpoints
  • Trading well above Graham Number ($16.31)
  • High P/B ratio
Future
75/100

Ref Growth rates

Positives
  • Massive YoY earnings growth (97.90%)
  • Strong revenue growth (32.90%)
Watchpoints
  • Forward P/E expansion suggests a potential earnings peak
Past
90/100

Ref Historical trends

Positives
  • Strong long-term price performance (5Y Change +229.9%)
  • Consistent growth in recent years
Watchpoints
  • Recent 1-week dip of 9.1%
Health
98/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Piotroski F-Score 8/9
  • Zero debt
  • High current and quick ratios
Watchpoints
  • Altman Z-Score not provided
Dividend
55/100

Ref Yield, Payout

Positives
  • Very low payout ratio (19.27%) ensures sustainability
Watchpoints
  • Low dividend yield (2.03%)
  • Low overall dividend strength score (35/100)

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$29.13
Analyst Target
$46.5
Upside/Downside
+59.6%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for DRD and closest competitors.

Updated 2026-04-24
DRD
DRDGOLD Limited
Primary
5Y
+229.9%
3Y
+188.5%
1Y
+93.0%
6M
+16.9%
1M
+4.4%
1W
-9.1%
KAL
Kaiser Aluminum Corporation
Peer
5Y
+65.6%
3Y
+172.3%
1Y
+195.9%
6M
+94.9%
1M
+37.5%
1W
+7.5%
SGM
Sigma Lithium Corporation
Peer
5Y
+395.5%
3Y
-47.7%
1Y
+176.2%
6M
+217.6%
1M
+87.5%
1W
+32.8%
ASH
Ashland Inc.
Peer
5Y
-17.4%
3Y
-38.5%
1Y
-9.3%
6M
+25.4%
1M
+6.6%
1W
+0.7%
CLM
Calumet, Inc.
Peer
5Y
+475.9%
3Y
+106.0%
1Y
+253.3%
6M
+90.1%
1M
+18.4%
1W
-3.3%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
18.55
Forward P/E
42.84
PEG Ratio
1.0
P/B Ratio
3.87
P/S Ratio
0.28
EV/Revenue
2.58
EV/EBITDA
5.24
Market Cap
$2.53B

Profitability

Profit margins and return metrics

Profit Margin 35.06%
Operating Margin 46.29%
Gross Margin 46.89%
ROE 34.71%
ROA 19.96%

Growth

Revenue and earnings growth rates

Revenue Growth +32.9%
Earnings Growth +97.9%
Q/Q Revenue Growth N/A
Q/Q Earnings Growth +98.7%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.0
Low debt
Current Ratio
3.01
Strong
Quick Ratio
2.49
Excellent
Cash/Share
$2.0

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2024

Total Assets
$10.3B
Liabilities
$2.6B
Equity
$7.7B
Debt/Equity
0.34x

Quarterly Earnings History

EPS performance vs analyst estimates

2026-08-19
$N/A
2008-05-09
$0.04
+80.0% surprise
2007-11-01
$-0.02
-142.6% surprise
2007-02-28
$-0.18
+41.0% surprise

Basic Materials Sector Comparison

Comparing DRD against 116 companies in the Basic Materials sector (7 bullish, 44 neutral, 65 bearish)
P/E Ratio
18.55
This Stock
vs
40.32
Sector Avg
-54.0% (Discount)
Return on Equity (ROE)
34.71%
This Stock
vs
-8.72%
Sector Avg
-498.0% (Below Avg)
Profit Margin
35.06%
This Stock
vs
-6.67%
Sector Avg
-625.4% (Weaker)
Debt to Equity
0.0
This Stock
vs
1.0
Sector Avg
-99.9% (Less Debt)
Revenue Growth
32.9%
This Stock
vs
36.92%
Sector Avg
-10.9% (Slower)
Current Ratio
3.01
This Stock
vs
5.68
Sector Avg
-46.9% (Weaker)

Similar Companies

Peer comparison within the same industry

SEC Filings

Recent regulatory filings from the SEC EDGAR database

20-F
20-F
2025-10-30

DRD filed its annual report on Form 20-F on October 30, 2025. Due to the limited information provided, specific financial highlights and risk factors are unavailable for summary.

20-F
20-F
2024-10-30

DRD filed its annual 20-F report on October 30, 2024, providing a comprehensive update on its financial position and operational performance. The filing contains the company's audited financial statements and detailed disclosures regarding its primary business risks.

Data sourced from SEC EDGAR. AI summaries generated automatically.

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
NONE
1 analysts
HC Wainwright & Co.
2026-01-30
Maintains
Buy Buy

Past News Coverage

Recent headlines mentioning DRD from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile